Beyond Regulation: Four PFAS Pressures Pharmaceutical Manufacturers Can’t Ignore

Why do promising transportation technologies succeed in pilots but struggle to gain widespread adoption? The answer goes far beyond the technology itself. Discover the hidden barriers between proving what works and creating the conditions needed to move next-generation mobility from successful demonstrations to lasting impact.

PFAS regulations are evolving fast, and medical device manufacturers can't afford to wait and see. In this blog, find out what's new in 2026 and how to prioritize action where it matters most.

Pharmaceutical manufacturers often know where they intentionally use PFAS, but far fewer can say where all the PFAS entering and leaving their facilities actually come from. In this blog, learn why PFAS exposure is a mass-balance challenge and what it takes to map it.

What if the mobile network you already rely on could also detect and understand activity in the physical world around you? In this blog, discover how ISAC and massive MIMO are setting the stage for networks that connect and sense.

For many pediatric conditions, researchers still lack the evidence needed to answer critical questions about treatment effectiveness. That challenge is at the center of a new Battelle initiative recently recognized by Amazon Web Services (AWS) through its 2026 AWS Imagine Grant Children’s Health Innovation Award.